Tag: Nasdaq IPO
-
Pyxis Oncology prices Nasdaq IPO at $16/share
•
LONDON, UK: Arix Bioscience plc, a global venture capital company focused on investing in and building breakthrough biotech…
-
Malin Corporation’s investee Immunocore prices upsized Nasdaq IPO
•
DUBLIN: Malin Corporation notes that its investee company, Immunocore, has announced the pricing of its initial public offering…
-
Nanobiotix announces key development milestones for 2021 after successful Nasdaq IPO
•
PARIS: Nanobiotix announced its global development plan for 2021 and beyond. Nanobiotix is a clinical-stage biotechnology company focused…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.